Skip to content
The Nexus
BUSINESSMay 26 · 08:30 UTCSTAT NEWSTahir Amin and Rohit Malpani

Opinion: The innovation trap: How pharma weaponizes a word to extend monopolies

Sen. John Cornyn questioned AbbVie CEO Richard Gonzalez during a 2019 congressional hearing about the company's 136 patents on Humira, a drug with the same active molecule used to treat multiple conditions. Gonzalez defended the patents as 'innovations,' extending patent protection beyond the original 2016 expiry. The exchange highlights concerns about pharmaceutical companies leveraging patent portfolios to maintain monopolies.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
John CornynpersonRichard GonzalezpersonAbbVieorganizationHumiratopicSenate Committee on Financeorganizationrheumatoid arthritistopicinflammatory bowel diseasetopicFDAorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting